The Importance of Pre Bone Marrow Transplantation Serology in Determining Subsequent Cytomegalovirus Infection: An Analysis of Risk Factors

References

• Lönnqvist B, Ringdén O, Wahren B, Gahrton G, Lundgren G. Cytomegalovirus infections associated with and preceding chronic graft-versus-host disease. Transplantation 1984; 38: 465–468
   PubMed Web of Science ®Google Scholar
• Meyers J D, Flournoy N, Thomas E D. Cytomegalovirus infection and specific cellmediated immunity after marrow transplant. J Infect Dis 1980; 142: 816–824
   PubMed Web of Science ®Google Scholar
• Neiman P E, Reeves W, Ray G, Flournoy N, Lerner K G, Sale G E, Thomas E D. A prospective analysis of interstitial and opportunistic viral infection among recipients or allogeneic bone marrow grafts. J Infect Dis 1977; 136: 754–767
   PubMed Web of Science ®Google Scholar
• Winston D J, Gale R P, Meyer D V, Young L S. Infectious complications of human bone marrow transplantation. Medicine 1979; 58: 1–31
   PubMed Web of Science ®Google Scholar
• Neiman P, Wasserman P B, Wentworth B B, Kao G F, Lerner K G, Storb R, Buckner C D, Clift R A, Fefer A, Fass L, Glucksberg H, Thomas E D. Interstitial pneumonia and cytomegalovirus infection as complications of human marrow transplantation. Transplantation 1973; 15: 478–485
   Google Scholar
• Watson J G. Problems of infection after bone marrow transplantation. J Clin Pathol 1983; 36: 683–692
   Google Scholar
• Winston D J, Ho W G, Howell C L, Miller M J, Mickey R, Martin W J, Lin C H, Gale R P. Cytomegalovirus infections associated with leucocyte transfusions. Ann Intern Med 1980; 93: 671–675
   PubMed Web of Science ®Google Scholar
• Meyers J D, Spencer H C, Watts J C, Gregg M B, Stewart J A, Troupin R H, Thomas E D. Cytomegalovirus pneumonia after human marrow transplantation. Ann Intern Med 1975; 82: 181–186
   PubMed Web of Science ®Google Scholar
• Pollard R B, Merigan T C. Perspectives for the control of cytomegalovirus infections in bone marrow transplant recipients. Transplant Proc 1978; 10: 241–245
   Google Scholar
• Thomas C D, Clift R A, Fefer A, Johnson F L, Neiman P E, Lerner K G, Glucksberg H, Buckner C D. Bone-marrow transplantation (parts 1 and 2). N Engl J Med 1975; 292: 832–843, 895–902
   PubMed Web of Science ®Google Scholar
• Ringdén O, Lonnqvist B, Lundgren G, Gahrton G, Groth C G, Möller E, Båryd I, Johansson B, Pihlstedt P, Gullbring B. Experience with a cooperative bone marrow transplantation program in Stockholm. Transplantation 1982; 33: 500–504
   PubMedGoogle Scholar
• Sundqvist V A, Wahren B. An interchangeable ELISA for cytomegalovirus antigen and antibody. J Virol Meth 1981; 2: 301–312
   PubMed Web of Science ®Google Scholar
• Peto R, Peto J. Asymptotically efficient rank invariant test procedures (with discussion). J R Statist Soc A 1972; 135: 185–206
   Web of Science ®Google Scholar
• Cox D R. Regression model and life-tables (with discussion). J R Statist Soc B 1972; 34: 187–220
   Web of Science ®Google Scholar
• Rubin R H, Cosimi A B, Tolkoff-Rubin N E, Russel P S, Hirsch M S. Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation 1977; 24: 458–464
   PubMed Web of Science ®Google Scholar
• Bortin M M, Gale R P, Kay H EM, Rimm A A. Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortality. JAMA 1983; 249: 1166–1175
   PubMed Web of Science ®Google Scholar
• Kay H EM, Watson J G, Jameson B, Morgenstern G R, Powels R L. Infections after bone marrow transplantation using cyclosporine. Transplantation 1983; 36: 491–495
   PubMed Web of Science ®Google Scholar
• Wahren B, Gahrton G, Linde A, Ljungman P, Lonnqvist B, Ringdén O, Sundqvist V A. Transfer and persistence of viral antibody-producing cells in bone marrow transplantation. J Infect Dis 1984; 150: 358
   PubMedGoogle Scholar
• Luby J P, Shasby D M. A sex difference in the prevalence of antibodies to cytomegalovirus. JAMA 1972; 222: 1290–1291
   PubMedGoogle Scholar
• Betts R F. Cytomegalovirus infection in transplant patients. Prog Med Virol 1982; 28: 44–64
   Google Scholar
• Ringdén O, Nilsson B. Death by graft-versus-host disease is associated with HLA mismatch, high recipient age, low marrow cell dose and splenectomy. Transplantation, In press
   Google Scholar
• Helgstrand E, Eriksson B, Johansson N G, Lannerö B, Larsson A, Misiorny A, Norén J O, Sjöberg B, Stenberg K, Stening G, Stridh S, Öberg B, Alenius S, Philipsson L. Trisodium phosphonoformate, a new antiviral compound. Science 1978; 201: 819
   PubMed Web of Science ®Google Scholar
• Hirsch M S, Scholley R T, Cosimi B. Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal transplant recipients. N Engl J Med 1983; 308: 1489
   PubMedGoogle Scholar
• Myers J D, Leszczynski J, Zaia J A. Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med 1983; 98: 442
   Google Scholar
• Paulin T, Ringdén O, Lönnqvist B. Faster immunological recovery after bone marrow transplantation in patients without cytomegalovirus infection. Transplantation, In press
   Google Scholar
• Rinaldo C R, Carney W P, Richter B S, Black P H, Hirsch M S. Mechanisms of immunosuppression in cytomegaloviral mononucleosis. J Infect Dis 1980; 141: 488–495
   PubMed Web of Science ®Google Scholar
• Pollard R B, Rand K H, Arvin A M, Merigan T C. Cell-mediated immunity to cytomegalovirus infection in normal subjects and cardiac transplant patients. J Infect Dis 1978; 137: 541–549
   PubMed Web of Science ®Google Scholar
• Schroff R W, Gale R P, Fahey J L. Regeneration of T cell subpopulations after bone marrow transplantation: cytomegalovirus infection and lymphoid subset imbalance. J Immunol 1982; 129: 1926–1930
   PubMed Web of Science ®Google Scholar
• Howard R J, Najarian J S. Cytomegalovirus-induced immune suppression. I. Humoral immunity. Clin Exp Immunol 1974; 18: 109–118
   Google Scholar